Monogram Technologies Inc. closed its Series D Preferred Stock Offering on October 1, 2024, raising approximately $11.7 million by selling 5,790,479 units, and received an Additional Information Request from the FDA regarding its marketing clearance application for the Monogram mB s TKA System, which is currently on hold pending a response within 180 days.